Detalles de la búsqueda
1.
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro-Inference from Data Review.
Semin Thromb Hemost
; 47(1): 63-73, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33348413
2.
Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talk.
Semin Thromb Hemost
; 47(7): 775-786, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255337
3.
In vivo roles of factor XII.
Blood
; 120(22): 4296-303, 2012 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22993391
4.
COVID-19: Not a thrombotic disease but a thromboinflammatory disease.
Ups J Med Sci
; 1292024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38327640
5.
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
Br J Haematol
; 160(6): 806-16, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23360261
6.
In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban.
J Thromb Thrombolysis
; 35(2): 131-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22843196
7.
Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study.
Biochem Biophys Res Commun
; 421(2): 335-42, 2012 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22507986
8.
Correcting a 25-year old error: Preanalytical conditions affect determination of von Willebrand factor variability as a function of menstrual cycle.
Am J Hematol
; 92(6): E117, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295559
9.
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate.
Br J Haematol
; 152(6): 758-65, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21250974
10.
Molecular aspects in clinical hemostasis research at Karolinska Institutet.
Biochem Biophys Res Commun
; 396(1): 131-4, 2010 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20494125
11.
Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
J Cardiovasc Pharmacol
; 53(1): 24-9, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19129740
12.
Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
Arterioscler Thromb Vasc Biol
; 27(2): 407-13, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17138937
13.
A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).
Thromb Res
; 171: 7-13, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30216822
14.
A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
Thromb Haemost
; 98(4): 871-82, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17938814
15.
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers.
J Neurotrauma
; 24(1): 174-80, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17263681
16.
Platelet dysfunction in patients with severe traumatic brain injury.
J Neurotrauma
; 24(11): 1699-706, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18001200
17.
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
Thromb Res
; 120(5): 653-61, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17275886
18.
Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
Blood Coagul Fibrinolysis
; 18(4): 365-70, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17473579
19.
Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Thromb Haemost
; 117(1): 75-85, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27761577
20.
Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
Blood Coagul Fibrinolysis
; 27(4): 401-7, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26650459